Impact of Dapagliflozin on Cardiac Remodelling in Patients with Chronic Heart Failure: The DAPA-MODA Study

Abstract

Dapagliflozin administration in stable out-setting patients with chronic HF and optimized therapy results in global reverse remodelling of cardiac structure, including reductions in LA volumes and improvement in left ventricular geometry and NT-proBNP concentrations.